col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Communicable Diseases Intensive Care Association: Infusion & Chemotherapy
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―11 Pathogenetic syndrome management of a patient with COVID-19 E.M. Khodosh
2 [GO] 2021―Jul―11 Neuroinvasion and neurological complications in COVID-19 O.A. Loskutov
3 [GO] 2021―Jul―11 Organoprotection in patients with COVID-19 V.K. Tashchuk
4 [GO] 2021―Jul―11 Features of infusion therapy in patients of the therapeutic profile during the COVID-19 pandemic O.A. Halushko
5 [GO] 2021―Jul―11 Tuberculosis in the context of the COVID-19 pandemic: what to expect and how to act? L.D. Todorico
6 [GO] 2021―Jul―11 2020 challenge: the potential options of COVID-19 therapy S.V. Kovalenko
7 [GO] 2021―Jul―11 The experience of management of COVID-19: focus on the pneumonia L.V. Moroz
8 [GO] 2021―Jul―11 Peculiarities of antimicrobial therapy of viral and bacterial pneumonia in patients with coronavirus disease O.M. Nesterenko
9 [GO] 2021―Jul―11 Peculiarities of care for patients with coronavirus infection. Important safety issues for health care workers A.M. Savych
10 [GO] 2021―Jul―10 Standardized protocol for ultrasound diagnosis of the lungs with COVID-19 O.M. Safonova, O.B. Dynnyk, G.L. Gumeniuk, V.A. Lukiianchuk, H.V. Linska, M.S. Brovchenko, et al. (+2)
11 [GO] 2021―Jul―10 Diagnostics of complicated course of community-acquired pneumonia of viral etiology (COVID-19) via using chest computed tomography М.І. Lynnyk, V.І. Іgnatieva, G.L. Gumeniuk, V.А. Svyatnenko, O.R. Tarasenko, O.L. Bororova
12 [GO] 2021―Jul―10 Evaluation of the treatment efficacy in the patients with viral etiology community acquired pneumonia (COVID-19) with the use of syndrome-pathogenetic small volume infusion therapy according to computer tomography data М.І. Lynnyk, V.І. Іgnatieva, G.L. Gumeniuk, O.R. Tarasenko, S.H. Opimakh, I.V. Chumak, et al. (+3)
13 [GO] 2021―Jul―09 Therapy of patients with COVID-19: clinical studies and recommendations in different countries S. V. Zaikov
14 [GO] 2020―Oct―12 Combination of the therapy of the anticoagulants and Tivortin in patients with cardiac ishemia at COVID-19 M.J. Dzhumaeva, A.I. Tabarov, Kh.T. Fayzulloev
15 [GO] 2020―Oct―12 Prospects of infusion therapy in the treatment of severe pulmonary tuberculosis in combination with COVID-19 L.D. Todoriko, M.I. Gumeniuk, I.O. Semianiv, T.A. Sprynsian, O.S. Denysov
16 [GO] 2020―Oct―12 Peculiarities of pulmonary tuberculosis in a COVID-19 pandemic L.D. Todoriko, І.О. Сем’янів
17 [GO] 2020―Oct―12 Features of infusion therapy in therapeutic patients during the COVID-19 pandemic O.A. Halushko
18 [GO] 2020―Oct―12 Role of markers of inflammation, severity and infusion therapy in COVID-19-defined pneumonia E.M. Khodosh
19 [GO] 2020―Oct―12 Peculiarities of antimicrobial therapy of viral-bacterial pneumonia in patients with coronavirus disease O.M. Nesterenko
20 [GO] 2020―Oct―10 COVID-19 and comorbid chronic diseases S. V. Zaikov
21 [GO] 2020―Oct―10 Peculiarities of tuberculosis in the COVID-19 pandemic L. D. Todoriko, I. O. Semianiv
22 [GO] 2020―Sep―11 Methods of visualization in the diagnosis of COVID-19 community-acquired pneumonia М.І. Gumeniuk, V.І. Іgnatieva, М.І. Lynnyk, G.L. Gumeniuk, V.А. Svyatnenko, M.G. Palivoda
23 [GO] 2020―Sep―11 Viral load as a marker of the risk of severe course and progression of COVID-19: a review Y. I. Feshchenko


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec